Iron is indispensable to life, but inside a cell it can become a chemical hazard. The metal helps mitochondria produce energy, enables hemoglobin to carry oxygen, and supports enzymes involved in DNA synthesis and metabolism. Yet iron that is not securely bound to proteins or stored in mineralized deposits can participate in reactions that generate highly reactive molecules. These molecules can attack DNA, proteins, and the fatty membranes surrounding cells. A new study from Whitehead Institute and the Massachusetts Institute of Technology has identified an unexpected line of defense against this threat: polyamines, a family of small, positively charged molecules found in unusually high concentrations inside cells.
The findings, published in Cell, suggest that polyamines act as molecular storage lockers for iron, binding or buffering the metal in a form that is less likely to trigger destructive chemistry. The work helps explain a long-standing biological puzzle. Cells maintain large pools of polyamines even though their best-known functions, including helping RNA fold and supporting cell growth, appear to require only a fraction of the total amount present. According to the researchers, these molecules serve an additional and previously underappreciated purpose: they help control the pool of chemically reactive iron that can otherwise push cells toward ferroptosis, a form of iron-dependent cell death caused by the breakdown of membrane lipids.
The research began with a broader question about why polyamines are so abundant. The Jain Lab studies RNA, the molecule that carries genetic instructions from DNA to the protein-making machinery and performs important structural and regulatory roles in its own right. Polyamines bind to RNA and can influence how it folds, but Ankur Jain, Whitney Henry, Pushkal Sharma, and their colleagues suspected that this explanation could not account for the extraordinary quantities of polyamines maintained by living cells. Their concentration can approach that of ATP, the molecule that supplies energy for many cellular reactions. Cells deprived of polyamines stop growing and dividing, but the known RNA-related functions do not fully explain why losing them is so damaging.
To search for hidden functions, the researchers used a genome-wide genetic screen. Rather than examining individual genes one at a time, this approach allows scientists to perturb or assess thousands of genes across a cell population and identify which pathways become especially important under particular conditions. The screen revealed that cells with reduced polyamine levels became unusually dependent on GPX4, an enzyme that protects cell membranes from oxidative damage. GPX4 converts toxic lipid hydroperoxides into less harmful compounds, preventing the chain reactions that can cause membranes to rupture. When this protection fails in the presence of reactive iron, cells can undergo ferroptosis.
The genetic results pointed toward a connection between polyamine loss, iron chemistry, and membrane damage. Cells with fewer polyamines also accumulated larger amounts of a protein that functions as an iron sponge, storing the metal in a mineralized and comparatively inert form. The response suggested that the cells were compensating for the loss of another iron-buffering system. The researchers proposed that polyamines themselves might normally keep iron in a safe state, reducing the amount available to catalyze harmful reactions. This distinction is important because total cellular iron is not necessarily a measure of iron toxicity. The dangerous fraction is labile or chemically reactive iron, which can move between molecular partners and participate in oxidation reactions.
To test the hypothesis directly, the team developed a fluorescent sensor capable of detecting chemically reactive iron inside living cells. The sensor changes the way cells glow according to the amount of reactive iron present, allowing researchers to follow iron chemistry in real time under a microscope rather than relying only on measurements from disrupted cells. The scientists combined this tool with an earlier sensor that reports polyamine levels. Watching both signals simultaneously revealed a striking inverse relationship. As polyamine concentrations fell, the amount of chemically reactive iron rose. The result provided direct evidence that polyamines help suppress the buildup of the iron fraction most capable of damaging cellular components.
The discovery also clarifies how iron, polyamines, and ferroptosis may be connected at the molecular level. When reactive iron is available, it can accelerate the oxidation of polyunsaturated fatty acids embedded in cell membranes. These oxidized lipids can initiate a self-amplifying chain reaction, progressively weakening the membrane. GPX4 interrupts that process by removing lipid peroxides, but cells with diminished polyamines appear to place greater reliance on the enzyme because they contain more reactive iron. In this model, polyamines act earlier in the sequence by limiting the chemical availability of iron, while GPX4 provides a second protective barrier against the lipid damage that follows when iron-driven oxidation occurs.
The findings could be especially relevant to cancer biology. Many cancer cells maintain elevated polyamine levels to support rapid growth, protein production, and cell division. Drugs that interfere with polyamine synthesis or transport have therefore been investigated as potential cancer treatments, but reducing polyamines alone has often produced limited results. The new work suggests one reason: when polyamines decline, cancer cells may activate compensatory iron-storage pathways and become dependent on GPX4 for survival. Combining a treatment that lowers polyamine levels with a drug that blocks GPX4 could, in principle, remove two protective systems at once, allowing reactive iron and lipid peroxidation to reach lethal levels. The researchers emphasize that this therapeutic strategy will require careful testing, since normal cells also depend on both iron regulation and antioxidant protection.
The biological implications may extend beyond cancer. Mutations affecting the movement and regulation of polyamines have been linked to a rare form of early-onset Parkinson’s disease, while abnormal iron accumulation has long been observed in the brains of people with Parkinson’s disease. The new findings do not establish that reactive iron caused by disrupted polyamine metabolism is responsible for neuron loss, but they provide a possible mechanistic connection between the two observations. Neurons are particularly vulnerable to oxidative damage because they are metabolically active and contain membranes rich in oxidation-sensitive lipids. If polyamine distribution or production is impaired, the resulting increase in labile iron could place additional pressure on antioxidant systems and contribute to cellular stress.
Beyond the proposed disease links, the fluorescent iron sensor may become one of the study’s most widely useful products. Researchers investigating aging, metabolism, cancer, neurodegeneration, and cellular stress can use it to observe reactive iron in living cells and compare its behavior with other molecular signals. The ability to measure labile iron dynamically could reveal when and where the metal becomes dangerous, rather than simply showing that total iron levels have changed. For now, the study recasts polyamines as more than helpers of RNA structure and cell proliferation. They appear to be part of a fundamental chemical defense system, quietly buffering one of biology’s most essential—and potentially destructive—metals.
Subject of Research: Polyamines, reactive iron, ferroptosis, cellular iron buffering, cancer biology, and neurodegeneration
Article Title: Polyamines buffer labile iron to suppress ferroptosis
Web References: https://mediasvc.eurekalert.org/Api/v1/Multimedia/ea90bd0f-d966-462c-a88a-12240ea8ea37/Rendition/low-res/Content/Public
References: Cell, “Polyamines buffer labile iron to suppress ferroptosis,” publication date: 14-Aug-2026
Image Credits: Pushkal Sharma / Whitehead Institute
Keywords: polyamines, labile iron, ferroptosis, GPX4, iron toxicity, cancer treatment, Parkinson’s disease, reactive oxygen species, lipid peroxidation, Whitehead Institute
